Hematological Malignancies
How to further improve DLBCL • Refractory – Use new drugs
– Subgroup of patients with high risk
• Relapse
– Higher dose chemotherapy – Prevent relapse
• At time of relapse
– Better salvage regimens
Made with FlippingBook